BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
35 results:

  • 1. Integration of Genomic Sequencing Drives Therapeutic Targeting of pdgfra in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic lymphoma.
    Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
    Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type.
    Xu T; Li Y; Liu Y; Ning B; Wu H; Wei Y
    Ann Hematol; 2023 Dec; 102(12):3521-3532. PubMed ID: 37702822
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::pdgfra rearrangement: Successful imatinib treatment in two cases.
    Bellani V; Croci GA; Bucelli C; Maronese CA; Alberti S; Iurlo A; Cattaneo D
    J Dermatol; 2023 Oct; 50(10):1330-1334. PubMed ID: 37248740
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
    Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FIP1L1-pdgfra fusion gene in T-lymphoblastic lymphoma: A case report.
    Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/pdgfra axis.
    Arribas AJ; Napoli S; Cascione L; Sartori G; Barnabei L; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone-Pittau R; Di Veroli A; Stathis A; Cruciani G; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
    Haematologica; 2022 Nov; 107(11):2685-2697. PubMed ID: 35484662
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mutations in ALK and TSC1 in a gastrointestinal stromal tumor: a case report.
    Song Q; Li G; Li Z; Ao S; Hou J; Lv G
    BMC Surg; 2021 Apr; 21(1):202. PubMed ID: 33879132
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ALK expressed in a gastrointestinal stromal tumor harboring pdgfra p. D842V mutation:a case report.
    Fan J; Yang M; Huang B; Wang Z; Luo D; Zhang J; Zhang P; Shi H; Li Y; Nie X
    Diagn Pathol; 2020 Jan; 15(1):8. PubMed ID: 32005261
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [The 8p11 myeloproliferative syndrome: a review of recent literature].
    Kirito K
    Rinsho Ketsueki; 2019; 60(9):1157-1165. PubMed ID: 31597839
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
    Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
    Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hypereosinophilic syndrome preceding a diagnosis of B-cell lymphoma.
    Samarghandi A; Ahuja S; Jindal V; Gupta S; Fulger I
    Tumori; 2018 Dec; 104(6):NP22-NP24. PubMed ID: 29714651
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cutaneous T-Cell lymphoma, a Novel Manifestation of pdgfra-Rearranged Neoplasm.
    Behdad A; Allen P; Lu X; Zhou XA; Guitart J; Chen Q; Pro B
    Am J Dermatopathol; 2018 Aug; 40(8):610-613. PubMed ID: 29505472
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A neoplasm with FIP1L1-pdgfra fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
    Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G
    Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BCR-pdgfra fusion in a T lymphoblastic leukemia/lymphoma.
    Yigit N; Wu WW; Subramaniyam S; Mathew S; Geyer JT
    Cancer Genet; 2015; 208(7-8):404-7. PubMed ID: 26095243
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor.
    Schiefer AI; Mesteri I; Berghoff AS; Haitel A; Schmidinger M; Preusser M; Birner P
    Histopathology; 2015 Dec; 67(6):799-805. PubMed ID: 25847631
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Inflammation, malignancy and immunology in gastrointestinal spindle cell tumors: what is beyond GIST?].
    Montgomery E; Voltaggio L; Vieth M
    Pathologe; 2014 Nov; 35 Suppl 2():207-13. PubMed ID: 25394969
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies.
    Shenoy S
    J Gastrointest Cancer; 2014 Dec; 45(4):421-30. PubMed ID: 25339426
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.